Skip to main content

Table 1 Baseline characteristics of subjects

From: Combination of long-acting HIV fusion inhibitor albuvirtide and LPV/r showed potent efficacy in HIV-1 patients

 

160 mg ABT + LPV/r

320 mg ABT + LPV/r

Randomized and treated

10

10

Excluded

1

1

SS for safety analysis

10

10

ITT for efficacy analysis

9

9

Sex (male/female)

8/2

7/3

Race (Han/other)

9/1

10/0

Age (years)

31.9 (18~48)

37.4 (24~47)

Body weight (kg)

67.8 (53~88)

65.4 (53~76)

BMI (kg/m2)

22.8 (19~27)

22.8 (18~26)

Baseline HIV-1 RNA (log10 copies/ml)

4.27 (3.53~4.70)

4.27 (3.32~5.14)

Baseline CD4 (cell/μl)

517.0 (350~774)

566.6 (350~1070)

  1. Data are presented as n or mean (range)